Smoking Cessation and Functional CT Assessment

PHASE4CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

March 19, 2018

Primary Completion Date

September 24, 2024

Study Completion Date

September 24, 2024

Conditions
Emphysema
Interventions
DRUG

Sildenafil 20 MG

Sildenafil, 20mg three times daily for 3 month period.

DRUG

Placebo Oral Tablet

Placebo manufactured to look like Sildenafil 20 MG

DIAGNOSTIC_TEST

Pulse wave velocity

Vascular pulse measurement at the radial, brachial, femoral, and carotid arteries are taken using a tonometer probe.

DIAGNOSTIC_TEST

Carotid artery compliance and stiffness

An echocardiogram is done by using a probe placed on the skin.

DIAGNOSTIC_TEST

Pressure wave reflection

Carotid pulse measurement taken using a tonometer probe

Trial Locations (1)

52242

University of Iowa Hospitals and Clinics, Iowa City

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Eric A. Hoffman

OTHER

NCT03382106 - Smoking Cessation and Functional CT Assessment | Biotech Hunter | Biotech Hunter